Lonza-Capsugel-Header

Lonza-Capsugel-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

Country

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Centaur Pharmaceuticals

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Boulder Peptide Symposium

Participation Not Confirmed

Update your Virtual Booth

Centaur Pharma Launches Novel Topical Solution WoxHeal for the Treatment of Diabetic ...

Lead Product(s): Diperoxochloric Acid

Therapeutic Area: Podiatry Product Name: WOXheal

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 08, 2020

Details:

WOXheal has dual mechanism of action, i.e. it has functional antibacterial action against Gram positive and gram negative bacteria and it also promotes growth of fibroblast cells, thereby yielding complete wound closure.